The Role of PARP inhibition in Clinical Practice

Auto enrolment

DNA Damage Response (DDR) and PARP inhibitors are promising but complex therapeutic strategies not yet widely known by healthcare professionals working in oncology. This accredited e-learning covers the role of PARP inhibitors in clinical practice, at present and in the near future.


Upon completion of this e-learning you will understand why, where and how PARP inhibitors work in clinical practice, providing you with tools you can apply in your daily practice. It is designed to support you in selecting the appropriate treatment strategy with PARP inhibitors in the appropriate patient population and to provide the best possible care.

EACCME Accreditation

COR2ED Checkpoint, made available on https://checkpoint.cor2ed.com and organized by COR2ED, is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists.

Each medical specialist should claim only those credits that he/she actually spent in the educational activity. The EACCME is an institution of the European Union of Medical Specialists (UEMS). Only those e-learning materials that are displayed on the UEMS-EACCME website have formally been accredited.

Through an agreement between the European Union of Medical Specialists (UEMS) and the American Medical Association (AMA), physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™.

Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.